Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 7 Venous Thrombosis 5 Venous Thromboembolism 3 Pulmonary Embolism 2 Thrombosis 1 Thromboembolism 1 Myeloproliferative Disorders 1 Hemostatic Disorders 1 Embolism 1

Interventions

edoxaban 1 apixaban 1 Warfarin 1 Rivaroxaban 1 Heparin, Low-Molecular-Weight 1 Dalteparin 1 Dabigatran 1 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Embolism × edoxaban × Clear all

NCT04618913 2026-05-26

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡